Dynasty Wealth Management LLC Trims Stock Position in Zoetis Inc. $ZTS

Dynasty Wealth Management LLC decreased its stake in Zoetis Inc. (NYSE:ZTS) by 82.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,074 shares of the company’s stock after selling 23,327 shares during the quarter. Dynasty Wealth Management LLC’s holdings in Zoetis were worth $742,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of ZTS. Halbert Hargrove Global Advisors LLC boosted its position in Zoetis by 496.6% in the 3rd quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock worth $25,000 after purchasing an additional 144 shares in the last quarter. REAP Financial Group LLC lifted its stake in shares of Zoetis by 201.5% in the 2nd quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock valued at $31,000 after purchasing an additional 131 shares during the period. NewSquare Capital LLC boosted its holdings in Zoetis by 69.1% during the second quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock worth $32,000 after buying an additional 85 shares in the last quarter. ORG Partners LLC grew its position in Zoetis by 56.8% during the second quarter. ORG Partners LLC now owns 232 shares of the company’s stock valued at $37,000 after buying an additional 84 shares during the period. Finally, Financial Consulate Inc. acquired a new stake in Zoetis during the third quarter valued at $39,000. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on ZTS shares. Bank of America lowered shares of Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 target price on the stock. in a research note on Monday, December 15th. HSBC set a $140.00 price objective on Zoetis in a research report on Wednesday, December 10th. JPMorgan Chase & Co. decreased their target price on Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 5th. Barclays started coverage on shares of Zoetis in a research note on Monday, December 8th. They issued an “equal weight” rating and a $136.00 price target on the stock. Finally, UBS Group reduced their price objective on shares of Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. Six equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, Zoetis presently has a consensus rating of “Hold” and a consensus price target of $160.18.

Zoetis Stock Down 1.1%

Shares of ZTS opened at $123.24 on Wednesday. The stock has a 50 day moving average price of $123.37 and a 200 day moving average price of $138.85. Zoetis Inc. has a one year low of $115.25 and a one year high of $177.40. The company has a debt-to-equity ratio of 1.31, a quick ratio of 2.28 and a current ratio of 3.64. The stock has a market capitalization of $54.31 billion, a price-to-earnings ratio of 20.75, a PEG ratio of 2.53 and a beta of 0.97.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The company had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. During the same quarter last year, the firm posted $1.58 EPS. The firm’s revenue for the quarter was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be paid a dividend of $0.53 per share. The ex-dividend date of this dividend is Tuesday, January 20th. This represents a $2.12 annualized dividend and a yield of 1.7%. This is a boost from Zoetis’s previous quarterly dividend of $0.50. Zoetis’s dividend payout ratio is currently 33.67%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.